Dr. Oliver Straub

Dr. Oliver Straub is a seasoned professional in the field of medical affairs and marketing, currently serving as the Director (Head) Medical Affairs Europe and International Markets at Hansa Biopharma since August 2021. With a robust background at Hansa Biopharma, Dr. Straub has held several key positions, including Therapeutic Area Lead and Medical Advisor, focusing on transplantation and immunology. Prior experience includes a role as Global Medical Advisor at ProteoMediX AG, specializing in diagnostics for oncology, and Business Development Manager at Ypsomed AG, where expertise was applied in drug delivery systems across various international markets. Dr. Straub's earlier roles involved senior medical advisory positions in global medical affairs at Mallinckrodt Pharmaceuticals and medical advisory functions at Novartis Pharma and Roche Pharma, underscoring extensive experience in medical marketing and clinical development. An academic foundation was established at the Institute of Neurobiology, University of Ulm, complemented by a degree from Ulm University.